<DOC>
	<DOCNO>NCT02825290</DOCNO>
	<brief_summary>This study evaluate outcomes frozen-thawed embryo transfer ( FET ) success rate modify luteal support - addition single injection HCG GnRH-agonist , day ET 4 day later , respectively vs. traditional luteal support vaginal progesterone ovulate woman .</brief_summary>
	<brief_title>Modified Luteal Support Frozen-Thawed Embryo Transfer - A Prospective Study</brief_title>
	<detailed_description>Background With recent trend toward single embryo transfer ( ET ) adopt attempt reduce risk multiple pregnancy , remain extra embryo cryopreserved , provide possibility conception initial fresh transfer . Moreover , several study compare fresh frozen-thawed embryo transfer ( FET ) cycle normal responder demonstrate significantly high clinical pregnancy rate per transfer FET versus fresh cycle . There several currently employ replacement protocol FET . The choice protocol depend individual woman 's ovarian function convenience method , well experience gain method physician . Whatever protocol use , success require optimal synchronization embryonic stage thaw date endometrium within endometrial preparation cycle . While consensus regard duration , route delivery dosage estrogen supplementation , optimal ultrasonographic endometrial appearance thickness , effect different mode luteal support remain unclear . Prompted study demonstrate high ongoing pregnancy rate follow transfer frozen-thawed embryos natural cycle spontaneous LH rise compare natural cycle control hCG final oocyte maturation report show improved pregnancy rate patient receive mid-luteal injection GnRH-agonist ( 0.1 mg triptorelin ) , investigator start begin June 2014 offer ovulatory patient regular menstrual cycle natural FET modify luteal support . Starting day spontaneous ovulation , patient receive daily vaginal progesterone , supplement single injection HCG GnRH-agonist , day ET 4 day later , respectively . The result study promising - investigator able show significant increase implantation rate ( 30 % vs. 17 % ; p &lt; 0.03 ) , clinical pregnancy ( 48 % vs. 26 % ; p &lt; 0.01 ) ongoing pregnancy ( 39 % vs. 20 % ; p &lt; 0.01 ) patient receive aforementioned modified luteal support protocol . After completion retrospective study investigator head prove superiority modify luteal support protocol ovulatory patient conduct prospective study . Materials &amp; Methods Study design - A prospective , randomize , blind study . Primary endpoint - Ongoing pregnancy . Secondary endpoint - Implantation rate , clinical pregnancy . Study sample - According previous , retrospective study investigator need 31 patient study arm order show increase 20 % clinical pregnancy 39 % ( confidence level 5 % , beta error level 50 % ) . The patient - The investigator offer patient treated unit frozen-thawed embryo transfer participate study . The randomization participant day embryo transfer computer program 1:1 enrollment ratio . All transfer perform experienced physician blind luteal support protocol . Both group treat accepted progesterone luteal support - start ovulation day - vaginal progesterone 90 mg ( Crinone ; Merck Serono , Hellerup , Denmark ) day . Study group - Patients study group receive additional two injection - first - recombinant hCG 250 mcg ( Ovitrelle ; Merck Serono ) transfer day second - GnRH-agonist 0.1 mg ( Decapeptyl ; Ferring Pharmaceuticals Israel ) 4 day embryo transfer day . Patients control group receive injection . B-hCG level examine 12 day embryo transfer positive ultrasound examination perform usual document pregnancy outcome . The data - The investigator use demographic data age , BMI , gynecological data gravida , para , etiology infertility data previous &amp; current IVF treatment number treatment , stimulation protocol , hormone level , number oocyte , embryo ' characteristic , etc . Statistics - Statistical analysis perform Student 's t-test Chi square , appropriate . Results present mean Â± standard deviation ; p &lt; 0.05 consider significant .</detailed_description>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>2040 year old woman Spontaneously ovulate woman Treated IVF unit frozenthawed embryo transfer At least one top quality embryo PGD patient More 4 previous embryo transfer</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Frozen-thawed embryo transfer ( FET )</keyword>
	<keyword>Luteal support</keyword>
	<keyword>Progesterone</keyword>
	<keyword>Natural cycle</keyword>
	<keyword>Cryopreservation</keyword>
	<keyword>IVF</keyword>
	<keyword>hCG</keyword>
	<keyword>GnRH-Agonist</keyword>
	<keyword>Pregnancy rate</keyword>
</DOC>